The online pipeline is undergoing construction. Please refer to this PowerPoint for most up-to-date pipeline.

Hit-to-Lead


Aston University, University of Birmingham, Tres Cantos GSK
Colorado State University
University of Illinois at Chicago, Myongji University
University of Illinois at Chicago
GlaxoSmithKline, TB Alliance
Texas A&M University
Lilly TB Drug Discovery Initative
TB Alliance, Rutgers University
TB Alliance, Calibr
Lilly TB Drug Discovery Initiative
TB Alliance, Sanofi
SPRINT-TB (National University of Singapore)
UPenn,TB Alliance
SPRINT-TB (National University of Singapore)

Lead Optmization


GlaxoSmithKline, Global Alliance for TB Drug Development
Anacor Pharmaceuticals, GlaxoSmithKline
UNESP/School of Pharmaceutical Sciences
Sanofi , TB Alliance
TB Alliance, University of Auckland, Janssen
Sequella
TB Alliance
GlaxoSmithKline
TB Alliance/Yonsei University
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)
TB Alliance, Sanofi
TB Alliance, Calibr
Kanury Rao, Sundeep Duggar

Pre-Clinical (Non-GLP)


TB Alliance, Sanofi
Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan, Lilly TB Drug Discovery Initiative, NIAID, IDRI, Lilly, YourEncore
Institute of Materia Medica
St Jude Children's Research Hospital, University of Tennessee Health Science Center, Colorado State University, University of Zurich, Microbiotix